Peter H Duesberg, a German-born American molecular biologist known both for his early groundbreaking work in cancer research ...

The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...

By Yadarisa Shabong Jan 20 (Reuters) - Britain's GSK and Japan's Shionogi said on Tuesday that Pfizer will exit their HIV ...

Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company.

Allegations of compromise and partiality have rocked the Christian Association of Nigeria and the Pentecostal Fellowship of ...

The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized ...

Attorneys say new transfer agreements and court tactics allow the U.S. to sidestep asylum rulings, risking removals to ...

Will it be a year of "fractured resilience"? Or "pragmatic empathy"? Will "MOUs" be the next global health strategy? Are we ...

Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to focus on its rare-disease pipeline, which is the subject of ongoing BD ...